add-on Maintenance Treatment of Patients With Severe Eosinophilic Asthma
1 clinical trials · Condition
◉ Watch add-on Maintenance Treatment of Patients With Severe Eosinophilic Asthma
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability and Pharmacokinetic of Recombinant Anti-IL-5 Humanized Monoclonal Antibody Injection (NCT04445038) | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 2020-06-12 |
Track add-on Maintenance Treatment of Patients With Severe Eosinophilic Asthma automatically
Every clearance here is in the API, with alerts when new ones post.